399 related articles for article (PubMed ID: 21564401)
1. Risk factors associated with fluoroquinolone-resistant tuberculosis in a Beijing tuberculosis referral hospital.
Liu CH; Yang N; Wang Q; Hu YL; Li L; Zhang GY; Zhu B
Respirology; 2011 Aug; 16(6):918-25. PubMed ID: 21564401
[TBL] [Abstract][Full Text] [Related]
2. Anti-tuberculosis drug resistance patterns and trends in a tuberculosis referral hospital, 1997-2009.
Liu CH; Li HM; Li L; Hu YL; Wang Q; Yang N; Wang S; Zhu B
Epidemiol Infect; 2011 Dec; 139(12):1909-18. PubMed ID: 21272420
[TBL] [Abstract][Full Text] [Related]
3. Risk factors associated with kanamycin-resistant tuberculosis in a Beijing tuberculosis referral hospital.
Yu HT; Wang Q; Yang N; Li HM; Liang JQ; Liu CH
J Med Microbiol; 2012 Jul; 61(Pt 7):960-967. PubMed ID: 22422574
[TBL] [Abstract][Full Text] [Related]
4. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
[TBL] [Abstract][Full Text] [Related]
5. Extensively drug-resistant tuberculosis in california, 1993-2006.
Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
[TBL] [Abstract][Full Text] [Related]
7. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
[TBL] [Abstract][Full Text] [Related]
8. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
9. Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China.
Li X; Wang H; Jing H; Wang Y; Yu C; Wang J; Liu Z; Graviss EA; Ma X
Int J Tuberc Lung Dis; 2012 May; 16(5):612-4. PubMed ID: 22410186
[TBL] [Abstract][Full Text] [Related]
10. [A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China].
Shen X; Li J; Gao Q; Xu B; Mei J
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):451-3. PubMed ID: 21781519
[TBL] [Abstract][Full Text] [Related]
11. [Impact of anti-tuberculosis drug resistance on treatment outcome of pulmonary tuberculosis patients receiving directly observed treatment strategy in Henan Province, China].
Wang GJ; Xu JY; Wang GB; Zhen XA; Gao SY; Du CM
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):527-30. PubMed ID: 17074265
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs.
Abate G; Miörner H; Ahmed O; Hoffner SE
Int J Tuberc Lung Dis; 1998 Jul; 2(7):580-4. PubMed ID: 9661826
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of multidrug and extensively drug-resistant tuberculosis in Beijing, China: a hospital-based retrospective study.
Wang D; Yang C; Kuang T; Lei H; Meng X; Tong A; He J; Jiang Y; Guo F; Dong M
Jpn J Infect Dis; 2010 Sep; 63(5):368-71. PubMed ID: 20859008
[TBL] [Abstract][Full Text] [Related]
14. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
15. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China.
Liang L; Wu Q; Gao L; Hao Y; Liu C; Xie Y; Sun H; Yan X; Li F; Li H; Fang H; Ning N; Cui Y; Han L
Thorax; 2012 Jul; 67(7):632-8. PubMed ID: 22403070
[TBL] [Abstract][Full Text] [Related]
16. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design.
Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D
J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis.
Pierre-Audigier C; Surcouf C; Cadet-Daniel V; Namouchi A; Heng S; Murray A; Guillard B; Gicquel B
Int J Tuberc Lung Dis; 2012 Feb; 16(2):221-3, i-ii. PubMed ID: 22236923
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
19. [The prevalence and risk factors of drug-resistant tuberculosis among migratory population in Shanghai, China].
Shen X; Shen M; Gui XH; Gao Q; Mei J
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):407-10. PubMed ID: 17673008
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
